Literature DB >> 2850009

The herpes simplex virus DNA polymerase: analysis of the functional domains.

C W Knopf1, K Weisshart.   

Abstract

The structural and functional organization of the herpes simplex virus type I (HSV-1) DNA polymerase enzyme of strain ANG was studied by a combination of sequence and immunobiochemical analyses. Comparison of the HSV-1 ANG DNA polymerase sequence with those of pro- and eukaryotic DNA polymerases resulted in the allocation of eleven conserved regions within the HSV-1 DNA polymerase. From the analysis of all currently identified mutations of temperature-sensitive and drug-resistant HSV-1 DNA polymerase mutants as well as from the degree of conservancy observed, it could be deduced that the amino-acid residues 597-961, comprising the homologous sequence regions IV-IX, constitute the major structural components of the catalytic domain of the enzyme which should accommodate the sites for polymerizing and 3'-to-5' exonucleolytic functions. Further insight into the structural organization was gained by the use of polyclonal antibodies responding specifically to the N-terminal, central and C-terminal polypeptide domains of the ANG polymerase. Each of the antisera was able to immunostain as well as to immunoprecipitate a viral polypeptide of 132 +/- 5 kDa that corresponded well to the molecular mass of 136 kDa predicted from the coding sequences. Enzyme-binding and neutralization studies confirmed that both functions, polymerase and 3'-to-5' exonuclease, are intimately related to each other, and revealed that, in addition to the sequences of the proposed catalytic domain, the very C-terminal sequences, except for amino-acid residues 1072-1146, are important for the catalytic functions of the enzyme, most likely effecting the binding to DNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850009     DOI: 10.1016/0167-4781(88)90100-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  16 in total

1.  A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.

Authors:  C B Hwang; K L Ruffner; D M Coen
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

2.  Molecular cloning of the cDNA for the catalytic subunit of human DNA polymerase delta.

Authors:  C L Yang; L S Chang; P Zhang; H Hao; L Zhu; N L Toomey; M Y Lee
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases.

Authors:  C H Tsai; M V Williams; R Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Engineered herpes simplex virus DNA polymerase point mutants: the most highly conserved region shared among alpha-like DNA polymerases is involved in substrate recognition.

Authors:  A I Marcy; C B Hwang; K L Ruffner; D M Coen
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Enzymatic activities of overexpressed herpes simplex virus DNA polymerase purified from recombinant baculovirus-infected insect cells.

Authors:  A I Marcy; P D Olivo; M D Challberg; D M Coen
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

6.  Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Authors:  S C Stanat; J E Reardon; A Erice; M C Jordan; W L Drew; K K Biron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

7.  Herpes Simplex Virus 1 DNA Polymerase RNase H Activity Acts in a 3'-to-5' Direction and Is Dependent on the 3'-to-5' Exonuclease Active Site.

Authors:  Jessica L Lawler; Purba Mukherjee; Donald M Coen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

8.  The pre-NH(2)-terminal domain of the herpes simplex virus 1 DNA polymerase catalytic subunit is required for efficient viral replication.

Authors:  Shariya L Terrell; Donald M Coen
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

9.  Thymidine kinase mutations conferring acyclovir resistance in herpes simplex type 1 recombinant viruses.

Authors:  Yan Sergerie; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

10.  In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.

Authors:  J T Matthews; R D Carroll; J T Stevens; M L Haffey
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.